[1]
GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2019; 5(1): 17-30. published
online 2019 Oct 21,
[http://dx.doi.org/10.1016/S2468-1253(19)30333-4.]
[http://dx.doi.org/10.1016/S2468-1253(19)30333-4.]
[2]
A. Bartoszek, J. Fichna, A. Tarasiuk, et al. Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer. Curr Drug Targets published online 2019 Nov 12.
[http://dx.doi.org/10.2174/1389450120666191112141901]
[http://dx.doi.org/10.2174/1389450120666191112141901]
[3]
A. Binienda, S. Ziolkowska, I.H. Hauge and , M. Salaga. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy. Curr Drug Targets published online 2020 May 3. doi:
[http://dx.doi.org/10.2174/1389450121666200504074922]
[http://dx.doi.org/10.2174/1389450121666200504074922]
[4]
A. Tarasiuk and G. Eibl. . Nutritional Support and Probiotics as a Potential Treatment of IBD. Curr Drug Targets published online 2020 May 3. doi:
[http://dx.doi.org/10.2174/1389450121666200504075519]
[http://dx.doi.org/10.2174/1389450121666200504075519]
[5]
R. Stavely, R. Abalo and , K. Nurgali. Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease. Curr Drug Targets published online 2020 May 16. doi:
[http://dx.doi.org/10.2174/1389450121666200516173242]
[http://dx.doi.org/10.2174/1389450121666200516173242]
[6]
H. Zatorski and R. Nakov. . Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges. Curr Drug Targets published online 2020 Jun 2. doi:
[http://dx.doi.org/10.2174/1389450121666200602125507]
[http://dx.doi.org/10.2174/1389450121666200602125507]
[7]
Wang H, Ye C, Wu Y, et al. Exosomes in Inflammatory Bowel Disease: What Have We Learned So Far? Curr Drug Targets published online 2020 Apr 27. doi:
[http://dx.doi.org/10.2174/1389450121666200428102330]
[http://dx.doi.org/10.2174/1389450121666200428102330]
[8]
A. Makaro, J. Fichna and M. Włodarczyk. . Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products. Curr Drug Targets published online 2020 Jul 26. doi:
[http://dx.doi.org/10.2174/1389450121666200727105218]
[http://dx.doi.org/10.2174/1389450121666200727105218]
Article Metrics
14
2